Home>Topics>Companies>Allergan

Allergan AGN

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Ultimate Stock-Pickers: Top Holdings of Top-Performing Managers

      Headlines

      Tue, 16 Dec 2014

      Uncertainty Market Cap (USD Mil) % Stock Holdings Allergan AGN 2 Wide 208.47 1.13 Medium 61,318 5.3 Appd Mats ..... with a 17.6% weighting for the benchmark index). Allergan AGN "> AGN , which has been the subject of a takeover battle

    2. Facial Aesthetics Market To 2020

      Commentary

      Tue, 9 Dec 2014

      include Valeant’s offer to acquire Allergan , Merz’s acquisition of BioFarm Medical ..... technologies. The key players covered are Allergan , Q-Med, Mentor, Medicis and Merz ..... technologies. Key players covered include Allergan , Q-Med AB, Mentor Corporation, Medicis

    3. For David Krempa - VRX

      Commentary

      Mon, 1 Dec 2014

      Do you expect to prepare an analyst note anytime soon on Valeant’s prospects following the abortive Allergan deal?

    4. Ackman's Pershing Square sees big payoff from Allergan deal

      Headlines

      Wed, 26 Nov 2014

      BOSTON (Reuters) - Hedge fund mogul William Ackman told investors they could see a $6 billion payday when he closes the chapter on Allergan Inc ., his firm's biggest bet of 2014.

    5. UPDATE 1-Ackman's Pershing Square sees big payoff from Allergan deal

      Headlines

      Wed, 26 Nov 2014

      (Adds details from Ackman's letter about other investments)

    6. Ackman's Pershing Square still holds 26.6 million Allergan shares

      Headlines

      Wed, 26 Nov 2014

      BOSTON, Nov 26 (Reuters) - Hedge fund manager William Ackman told investors in a letter that his firm still owns 26.6 million shares in Allergan Inc . which were valued at $5.6 billion one week after...

    7. Let's Make a Deal: The Outlook for Merger Funds

      Headlines

      Tue, 25 Nov 2014

      The recent spate of merger activity on Wall Street (including last week's $66 billion acquisition of Allergan by Actavis ACT) has raised the profile of a niche segment of the alternative mutual fund universe, merger-arbitrage funds

    8. CORRECTED-BRIEF-Valeant Pharma reports 0.1 percent stake in Allergan

      Headlines

      Fri, 21 Nov 2014

      (Corrects first bullet point to remove incorrect reference to Valeant's prior stake in Allergan )

    9. CORRECTED-Valeant slashes stake in Allergan after losing bid

      Headlines

      Fri, 21 Nov 2014

      Nov 20 (Reuters) - Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent, three days after Actavis Plc trumped its offer for the Botox maker.

    10. Valeant slashes stake in Allergan after losing bid

      Headlines

      Thu, 20 Nov 2014

      Nov 20 (Reuters) - Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent from 9.7 percent, three days after Actavis Plc trumped its offer for the Botox maker.

    « Prev12345Next »
    Content Partners